Analysts expect Cullinan Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.23 M | 0.00 | 0.00 | 0.00 | 14.18 M | 8.99 M | 2.24 M | 4.75 M | 18.36 M | 16.69 M | 9.82 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.48 M | 0.00 | 0.00 | 0.00 | 12.43 M | 7.55 M | 2.05 M | 4.26 M | 15.18 M | 15.69 M | 8.57 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.86 M | 0.00 | 0.00 | 0.00 | 13.30 M | 8.27 M | 2.15 M | 4.51 M | 16.77 M | 16.19 M | 9.20 M |
Analysts expect Cullinan Therapeutics, Inc. to report earnings per share of -0.87 for Q3 26, against a range of -0.96 to -0.78. The most recent reported quarter, Q2 26, came in at -0.81, a 6.6% miss against the -0.76 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.69 | -0.73 | -0.74 | -1.07 | -0.77 | -0.77 | -0.75 | -0.81 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.73 | -0.66 | -0.71 | -0.85 | -0.85 | -0.80 | -0.86 | -0.74 | -0.78 | -0.63 | -0.63 | -0.75 | -0.73 | -0.59 | -0.63 | -0.72 | ||||||||||
| Low Estimate | -0.81 | -0.74 | -0.83 | -0.97 | -0.93 | -0.92 | -0.92 | -0.78 | -0.96 | -0.75 | -0.71 | -0.87 | -0.83 | -0.67 | -0.73 | -0.88 | ||||||||||
| Consensus Estimate | -0.77 | -0.70 | -0.77 | -0.91 | -0.89 | -0.86 | -0.89 | -0.76 | -0.87 | -0.69 | -0.67 | -0.81 | -0.78 | -0.63 | -0.68 | -0.80 |
Pull Wall Street consensus for Cullinan Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CGEM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CGEM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CGEM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();